AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Eli Lilly and Alexandria Real Estate Equities Open New San Diego Facility Through Gateway Labs Partnership
ByAinvest
Friday, Sep 26, 2025 9:29 am ET1min read
Eli Lilly has partnered with Alexandria Real Estate Equities to open a new Gateway Labs facility in San Diego. The facility will serve as a hub for the company's research and development efforts. The partnership aims to leverage Eli Lilly's scientific expertise and Alexandria's real estate expertise to create an environment conducive to innovation. The facility is expected to support Eli Lilly's efforts to develop new treatments for various diseases.
Eli Lilly and Company (NYSE: LLY) and Alexandria Real Estate Equities (NYSE: ARE) have announced the opening of a new Gateway Labs facility in San Diego, California. The strategic partnership aims to leverage Eli Lilly's scientific expertise and Alexandria's real estate infrastructure to create an environment conducive to innovation in biotechnology.The new Gateway Labs site, located on the One Alexandria Square Megacampus in Torrey Pines, features 82,514 square feet of flexible laboratory and office space designed to accommodate up to 15 life sciences companies and more than 250 employees [1]. The facility is equipped with advanced scientific equipment and collaboration spaces, providing a state-of-the-art environment for early-stage biotech companies.
The Gateway Labs model offers startups access to wet lab facilities, tailored scientific engagement, and strategic guidance to help navigate the complexities of drug discovery and development. Since the first Gateway Labs site opened in 2019, LGL-based companies have raised over $2 billion in capital, supporting the development of more than 50 therapeutics and platforms currently in progress [1].
The partnership between Eli Lilly and Alexandria Real Estate Equities represents a significant expansion of the Gateway Labs platform. The new facility combines Alexandria's real estate infrastructure and operational expertise with Lilly's scientific resources, mentorship, and venture capital network. Initial tenants include venture-backed biotech companies focusing on Alzheimer's, Parkinson's, cardiovascular diseases, and oncology research [2].
The opening of the new Gateway Labs site in San Diego is expected to support Eli Lilly's efforts to develop new treatments for various diseases. The facility will also enhance Alexandria's tenant offering, potentially increasing occupancy rates and rental premiums at the One Alexandria Square Megacampus.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet